(19)

(11)

EP 4 522 191 A1

(12)

(43) Date of publication: 19.03.2025 Bulletin 2025/12 (21) Application number: 23726983.2 (22) Date of filing: 15.05.2023

(51) International Patent Classification (IPC):  A61K 38/04(2006.01) A61P 3/00(2006.01) A61P 17/02(2006.01) A61P 9/10(2006.01) A61K 38/16(2006.01) A61P 17/00(2006.01) A61P 9/00(2006.01) (52) Cooperative Patent Classification (CPC): A61K 38/04; A61K 38/16; A61P 3/00; A61P 17/00; A61P 17/02; A61P 9/00; A61P 9/10 (86) International application number: PCT/EP2023/062956 (87) International publication number: WO 2023/218094 (16.11.2023 Gazette 2023/46)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA Designated Validation States: KH MA MD TN (30) Priority: 13.05.2022 EP 22173230 (71) Applicant: Coegin Pharma AB 223 81 Lund (SE)	(72) Inventors: HULTGÅRDH NILSSON, Anna 247 99 Genarp (SE) NILSSON, Jan 247 99 Genarp (SE) (74) Representative: Høiberg P/S  Adelgade 12 1304 Copenhagen K 1304 Copenhagen K (DK)